REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 188 filers reported holding REGENXBIO INC in Q4 2020. The put-call ratio across all filers is 0.41 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,078,375 | -14.6% | 430,035 | +3.7% | 0.00% | -50.0% |
| Q2 2023 | $8,289,433 | +6.8% | 414,679 | +1.0% | 0.00% | 0.0% |
| Q1 2023 | $7,760,626 | -20.2% | 410,398 | -4.3% | 0.00% | 0.0% |
| Q4 2022 | $9,728,564 | -24.6% | 428,949 | -12.1% | 0.00% | -33.3% |
| Q3 2022 | $12,903,000 | +23.5% | 488,174 | +15.4% | 0.00% | +50.0% |
| Q2 2022 | $10,451,000 | -24.1% | 423,114 | +2.0% | 0.00% | 0.0% |
| Q1 2022 | $13,774,000 | -1.2% | 415,015 | -2.7% | 0.00% | 0.0% |
| Q4 2021 | $13,944,000 | -31.4% | 426,402 | -12.0% | 0.00% | -50.0% |
| Q3 2021 | $20,319,000 | +9.4% | 484,718 | +1.4% | 0.00% | +33.3% |
| Q2 2021 | $18,580,000 | +24.1% | 478,260 | +9.0% | 0.00% | 0.0% |
| Q1 2021 | $14,966,000 | -15.6% | 438,745 | +12.3% | 0.00% | 0.0% |
| Q4 2020 | $17,723,000 | +61.4% | 390,732 | -2.1% | 0.00% | +50.0% |
| Q3 2020 | $10,979,000 | -30.6% | 398,940 | -7.1% | 0.00% | -50.0% |
| Q2 2020 | $15,811,000 | +19.0% | 429,294 | +4.6% | 0.00% | 0.0% |
| Q1 2020 | $13,288,000 | -20.3% | 410,365 | +0.8% | 0.00% | 0.0% |
| Q4 2019 | $16,681,000 | +8.9% | 407,146 | -5.4% | 0.00% | 0.0% |
| Q3 2019 | $15,315,000 | -30.0% | 430,215 | +1.0% | 0.00% | -20.0% |
| Q2 2019 | $21,889,000 | -8.7% | 426,105 | +1.9% | 0.01% | -16.7% |
| Q1 2019 | $23,966,000 | +38.3% | 418,183 | +1.3% | 0.01% | +20.0% |
| Q4 2018 | $17,325,000 | -44.0% | 412,988 | +0.8% | 0.01% | -37.5% |
| Q3 2018 | $30,946,000 | +20.1% | 409,889 | +14.2% | 0.01% | +14.3% |
| Q2 2018 | $25,762,000 | +191.4% | 359,040 | +21.2% | 0.01% | +250.0% |
| Q1 2018 | $8,841,000 | -10.2% | 296,191 | +0.0% | 0.00% | 0.0% |
| Q4 2017 | $9,846,000 | -5.3% | 296,110 | -6.1% | 0.00% | -33.3% |
| Q3 2017 | $10,393,000 | +73.0% | 315,405 | +3.7% | 0.00% | +50.0% |
| Q2 2017 | $6,008,000 | +44.1% | 304,184 | +40.8% | 0.00% | +100.0% |
| Q1 2017 | $4,169,000 | +4.5% | 215,982 | +0.4% | 0.00% | 0.0% |
| Q4 2016 | $3,989,000 | +42.9% | 215,069 | +7.9% | 0.00% | 0.0% |
| Q3 2016 | $2,791,000 | +97.2% | 199,270 | +12.7% | 0.00% | – |
| Q2 2016 | $1,415,000 | +89.9% | 176,801 | +156.1% | 0.00% | – |
| Q1 2016 | $745,000 | -34.5% | 69,026 | +0.7% | 0.00% | – |
| Q4 2015 | $1,138,000 | – | 68,530 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 847,424 | $13,948,599 | 12.64% |
| Sonic GP LLC | 518,079 | $8,527,580 | 8.28% |
| MPM BioImpact LLC | 656,718 | $10,809,578 | 2.89% |
| Redmile Group, LLC | 2,574,042 | $42,368,731 | 2.02% |
| ArchPoint Investors | 224,278 | $3,691,616 | 1.41% |
| WS MANAGEMENT LLLP | 618,131 | $10,174,436 | 0.82% |
| Redwood Wealth Management Group, LLC | 14,360 | $236,366 | 0.28% |
| HARBOR CAPITAL ADVISORS, INC. | 48,559 | $799,281 | 0.17% |
| PRENTISS SMITH & CO INC | 11,240 | $185,010 | 0.14% |
| LIBERTY ONE INVESTMENT MANAGEMENT, LLC | 36,522 | $601,152 | 0.09% |